Healio

First patient dosed with electron accelerator-produced copper in neuroblastoma study

Please provide your email address to receive an email when new articles are posted on . The first patient has been dosed in a clinical trial with electron accelerator-produced Cu-67, according to a ...
Business Wire

First Participant Treated Using NorthStar Medical Radioisotopes’ Electron Accelerator-produced Copper-67 (Cu-67) in Clarity Pharmaceuticals’ Phase I/IIa Theranostic ...

BELOIT, Wis.--(BUSINESS WIRE)--NorthStar Medical Radioisotopes, LLC (“NorthStar"), a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic ...
Business Wire

NorthStar Medical Radioisotopes and IBA Sign Agreement for Two Additional Rhodotron® Electron Beam Accelerators for Commercial Production of Radioisotopes

BELOIT, Wis. & LOUVAIN-LA-NEUVE, Belgium--(BUSINESS WIRE)--NorthStar Medical Radioisotopes, LLC (‘NorthStar’), a global innovator in the development, production and commercialization of ...
Phys.org

Laser plasma accelerator achieves enhanced electron beam quality for practical applications

Laser plasma acceleration is a potentially disruptive technology: It could be used to build far more compact accelerators and open up new use cases in fundamental research, industry and health.